We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
5 similar Registration Rights Agreement contracts by Cell Therapeutics Inc, Cti Biopharma Corp, MEI Pharma, Inc.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 27th, 2014 • Cti Biopharma Corp • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of October 24, 2014, by and among (i) CTI Biopharma Corp. (formerly known as Cell Therapeutics, Inc.), a Washington corporation (the “Company”), (ii) Chroma Therapeutics Limited (“Chroma”) (the “Initial Holder”), and (iii) each person or entity that subsequently becomes a party to this Agreement pursuant to, and in accordance with, the provisions of Section 12 hereof (collectively, the “Holder Permitted Transferees,” and each individually, a “Holder Permitted Transferee”).
Standard Contracts
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 15th, 2013 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of November 14, 2013, by and among (i) Cell Therapeutics, Inc., a Washington corporation (the “Company”), (ii) Baxter Healthcare SA, a company organized under the laws of Switzerland (the “Initial Holder”), and (iii) each person or entity that subsequently becomes a party to this Agreement pursuant to, and in accordance with, the provisions of Section 12 hereof (collectively, the “Holder Permitted Transferees,” and each individually, a “Holder Permitted Transferee”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 8th, 2012 • MEI Pharma, Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of [ ], 2012, by and among (i) MEI Pharma, Inc., a Delaware corporation (the “Company”), (ii) S*BIO Pte Ltd., a Singapore private limited company (the “Initial Holder”), and (iii) each person or entity that subsequently becomes a party to this Agreement pursuant to, and in accordance with, the provisions of Section 12 hereof (collectively, the “Holder Permitted Transferees,” and each individually, a “Holder Permitted Transferee”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 5th, 2012 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of May 31, 2012, by and among (i) Cell Therapeutics, Inc., a Washington corporation (the “Company”), (ii) S*BIO Pte Ltd., a Singapore private limited company (the “Initial Holder”), and (iii) each person or entity that subsequently becomes a party to this Agreement pursuant to, and in accordance with, the provisions of Section 12 hereof (collectively, the “Holder Permitted Transferees,” and each individually, a “Holder Permitted Transferee”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 24th, 2012 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of , 2012, by and among (i) Cell Therapeutics, Inc., a Washington corporation (the “Company”), (ii) S*BIO Pte Ltd., a Singapore private limited company (the “Initial Holder”), and (iii) each person or entity that subsequently becomes a party to this Agreement pursuant to, and in accordance with, the provisions of Section 12 hereof (collectively, the “Holder Permitted Transferees,” and each individually, a “Holder Permitted Transferee”).